The Cost-Effectiveness of Bevacizumab in Advanced Ovarian Cancer Using Evidence From the ICON7 Trial
Value in Health - United Kingdom
doi 10.1016/j.jval.2016.01.013
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2016
Authors
Publisher
Elsevier BV